Related Experiment Video

Updated: Apr 19, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K

Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells

Wenchao Zhou1,2, Aili Cao2, Li Wang2

  • 1Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Cell Biochemistry and Biophysics
|December 20, 2014
PubMed

Insights

Kurarinone enhances the effectiveness of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in gastric cancer cells. This combination therapy, by inhibiting STAT3 signaling, promotes apoptosis and may offer a new treatment for advanced gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows anti-cancer potential but has limited efficacy in gastric cancer.
  • Gastric cancer cells exhibit resistance to TRAIL-induced apoptosis, necessitating combination strategies.

Purpose of the Study:

  • To investigate the synergistic effect of kurarinone and TRAIL on gastric cancer cell apoptosis.
  • To elucidate the molecular mechanisms underlying the combined therapeutic effect.

Main Methods:

  • Gastric cancer cell lines (SGC7901) were treated with TRAIL and/or kurarinone.
  • Cell viability was assessed using MTT assays.
  • Apoptosis, cell cycle, and protein expression (Mcl-1, c-FLIP, STAT3 signaling) were analyzed by flow cytometry, western blot, and q-RT-PCR.

Main Results:

  • Kurarinone significantly potentiated TRAIL-induced apoptosis and G2/M cell cycle arrest.
  • The combination led to downregulation of anti-apoptotic proteins Mcl-1 and c-FLIP.
  • Inhibition of STAT3 signaling by kurarinone was identified as a key mechanism, similar to a specific STAT3 inhibitor.

Conclusions:

  • Kurarinone synergizes with TRAIL to induce apoptosis in human gastric cancer cells.
  • The observed synergy is mediated by the downregulation of Mcl-1 and c-FLIP through STAT3 pathway inhibition.
  • Combined TRAIL and kurarinone therapy presents a potential treatment strategy for advanced gastric cancer.
Keywords:
ApoptosisGastric cancerKurarinoneSTAT3TRAIL

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K